Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
Rummel, Mathias J, Prof Dr, Niederle, Norbert, Prof, Maschmeyer, Georg, Prof, Banat, G Andre, MD, von Grünhagen, Ulrich, MD, Losem, Christoph, MD, Kofahl-Krause, Dorothea, MD, Heil, Gerhard, Prof, Welslau, Manfred, MD, Balser, Christina, MD, Kaiser, Ulrich, Prof, Weidmann, Eckhart, Prof, Dürk, Heinz, MD, PhD, Ballo, Harald, MD, Stauch, Martina, MD, Roller, Fritz, MD, Barth, Juergen, Pharm, Hoelzer, Dieter, Prof, Hinke, Axel, PhD, Brugger, Wolfram, Prof
Published in The Lancet (British edition) (06.04.2013)
Published in The Lancet (British edition) (06.04.2013)
Get full text
Journal Article
Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96–02/AUO AP 09/95 Trial
Wiegel, Thomas, Bartkowiak, Detlef, Bottke, Dirk, Bronner, Claudia, Steiner, Ursula, Siegmann, Alessandra, Golz, Reinhard, Störkel, Stephan, Willich, Normann, Semjonow, Axel, Stöckle, Michael, Rübe, Christian, Rebmann, Udo, Kälble, Tilman, Feldmann, Horst Jürgen, Wirth, Manfred, Hofmann, Rainer, Engenhart-Cabillic, Rita, Hinke, Axel, Hinkelbein, Wolfgang, Miller, Kurt
Published in European urology (01.08.2014)
Published in European urology (01.08.2014)
Get full text
Journal Article
Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial
Hegewisch-Becker, Susanna, Prof, Graeven, Ullrich, MD, Lerchenmüller, Christian A, MD, Killing, Birgitta, MD, Depenbusch, Reinhard, MD, Steffens, Claus-Christoph, MD, Al-Batran, Salah-Eddin, Prof, Lange, Thoralf, Prof, Dietrich, Georg, MD, Stoehlmacher, Jan, Prof, Tannapfel, Andrea, Prof, Reinacher-Schick, Anke, Prof, Quidde, Julia, MD, Trarbach, Tanja, MD, Hinke, Axel, PhD, Schmoll, Hans-Joachim, Prof, Arnold, Dirk, Prof
Published in The lancet oncology (01.10.2015)
Published in The lancet oncology (01.10.2015)
Get full text
Journal Article
Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95
WIEGEL, Thomas, BOTTKE, Dirk, RÜBE, Christian, WEISSBACH, Lothar, ALTHAUS, Peter, REBMANN, Udo, KÄLBLE, Tilman, FELDMANN, Horst Jürgen, WIRTH, Manfred, HINKE, Axel, HINKELBEIN, Wolfgang, MILLER, Kurt, STEINER, Ursula, SIEGMANN, Alessandra, GOLZ, Reinhard, STÖRKEL, Stephan, WILLICH, Norman, SEMJONOW, Axel, SOUCHON, Rainer, STÖCKLE, Michael
Published in Journal of clinical oncology (20.06.2009)
Published in Journal of clinical oncology (20.06.2009)
Get full text
Journal Article
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial
Rummel, Mathias, Prof, Kaiser, Ulrich, Prof, Balser, Christina, MD, Stauch, Martina, MD, Brugger, Wolfram, Prof, Welslau, Manfred, MD, Niederle, Norbert, Prof, Losem, Christoph, MD, Boeck, Hans-Peter, MD, Weidmann, Eckhart, Prof, von Gruenhagen, Ulrich, MD, Mueller, Lothar, MD, Sandherr, Michael, MD, Hahn, Lars, MD, Vereshchagina, Julia, MD, Kauff, Frank, PhD, Blau, Wolfgang, MD, Hinke, Axel, PhD, Barth, Juergen, Pharmacist
Published in The lancet oncology (01.01.2016)
Published in The lancet oncology (01.01.2016)
Get full text
Journal Article
Prostate-Specific Antigen Persistence After Radical Prostatectomy as a Predictive Factor of Clinical Relapse-Free Survival and Overall Survival: 10-Year Data of the ARO 96-02 Trial
Wiegel, Thomas, MD, Bartkowiak, Detlef, PhD, Bottke, Dirk, MD, Thamm, Reinhard, MD, Hinke, Axel, PhD, Stöckle, Michael, MD, Rübe, Christian, MD, Semjonow, Axel, MD, Wirth, Manfred, MD, Störkel, Stephan, MD, Golz, Reinhard, MD, Engenhart-Cabillic, Rita, MD, Hofmann, Rainer, MD, Feldmann, Horst-Jürgen, MD, Kälble, Tilman, MD, Siegmann, Alessandra, MD, Hinkelbein, Wolfgang, MD, Steiner, Ursula, MD, Miller, Kurt, MD
Published in International journal of radiation oncology, biology, physics (01.02.2015)
Published in International journal of radiation oncology, biology, physics (01.02.2015)
Get full text
Journal Article
Is the addition of a neurokinin-1 receptor antagonist beneficial in moderately emetogenic chemotherapy?—a systematic review and meta-analysis
Jordan, Karin, Blättermann, Luisa, Hinke, Axel, Müller-Tidow, Carsten, Jahn, Franziska
Published in Supportive care in cancer (01.01.2018)
Published in Supportive care in cancer (01.01.2018)
Get full text
Journal Article
IMWG consensus on maintenance therapy in multiple myeloma
Ludwig, Heinz, Durie, Brian G.M., McCarthy, Philip, Palumbo, Antonio, San Miguel, Jésus, Barlogie, Bart, Morgan, Gareth, Sonneveld, Pieter, Spencer, Andrew, Andersen, Kenneth C., Facon, Thierry, Stewart, Keith A., Einsele, Hermann, Mateos, Maria-Victoria, Wijermans, Pierre, Waage, Anders, Beksac, Meral, Richardson, Paul G., Hulin, Cyrille, Niesvizky, Ruben, Lokhorst, Henk, Landgren, Ola, Bergsagel, P. Leif, Orlowski, Robert, Hinke, Axel, Cavo, Michele, Attal, Michel
Published in Blood (29.03.2012)
Published in Blood (29.03.2012)
Get full text
Journal Article
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)
Tintelnot, Joseph, Goekkurt, Eray, Binder, Mascha, Thuss-Patience, Peter, Lorenzen, Sylvie, Knorrenschild, Jorge Riera, Kretzschmar, Albrecht, Ettrich, Thomas, Lindig, Udo, Jacobasch, Lutz, Pink, Daniel, Al-Batran, Salah-Eddin, Hinke, Axel, Hegewisch-Becker, Susanna, Nilsson, Sven, Bokemeyer, Carsten, Stein, Alexander
Published in BMC cancer (01.06.2020)
Published in BMC cancer (01.06.2020)
Get full text
Journal Article
Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer
HEINEMANN, Volker, QUIETZSCH, Detlef, VEHLING-KAISER, Ursula, FUCHS, Martin, FLECKENSTEIN, Doris, GESIERICH, Wolfgang, UTHGENANNT, Dirk, EINSELE, Hermann, HOLSTEGE, Axel, HINKE, Axel, SCHALHORN, Andreas, WILKOWSKI, Ralf, GIESELER, Frank, GONNERMANN, Michael, SCHÖNEKÄS, Herbert, ROST, Andreas, NEUHAUS, Horst, HAAG, Caroline, CLEMENS, Michael, HEINRICH, Bernard
Published in Journal of clinical oncology (20.08.2006)
Published in Journal of clinical oncology (20.08.2006)
Get full text
Journal Article
Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Leucovorin Plus Oxaliplatin in Metastatic Colorectal Cancer: A Final Report of the AIO Colorectal Study Group
PORSCHEN, Rainer, ARKENAU, Hendrik-Tobias, SCHMIEGEL, Wolff, SCHMOLL, Hans-Joachim, KUBICKA, Stephan, GREIL, Richard, SEUFFERLEIN, Thomas, FREIER, Werner, KRETZSCHMAR, Albrecht, GRAEVEN, Ullrich, GROTHEY, Axel, HINKE, Axel
Published in Journal of clinical oncology (20.09.2007)
Published in Journal of clinical oncology (20.09.2007)
Get full text
Journal Article
Intense Dose-Dense Sequential Chemotherapy With Epirubicin, Paclitaxel, and Cyclophosphamide Compared With Conventionally Scheduled Chemotherapy in High-Risk Primary Breast Cancer: Mature Results of an AGO Phase III Study
MOEBUS, Volker, JACKISCH, Christian, HARBECK, Nadia, VON MINCKWITZ, Gunter, RUNNEBAUM, Ingo B, HINKE, Axel, KREIENBERG, Rolf, KONECNY, Gottfried E, UNTCH, Michael, LUECK, Hans-Joachim, DU BOIS, Andreas, THOMSSEN, Christoph, KURBACHER, Christian, KUHN, Walther, NITZ, Ulrike, SCHNEEWEISS, Andreas, HUOBER, Jens
Published in Journal of clinical oncology (10.06.2010)
Published in Journal of clinical oncology (10.06.2010)
Get full text
Journal Article
Efficacy of Oxaliplatin Plus Capecitabine or Infusional Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Randomized Trials
ARKENAU, Hendrik-Tobias, ARNOLD, Dirk, SCHMOLL, Hans-Joachim, PORSCHEN, Rainer, CASSIDY, Jim, DIAZ-RUBIO, Eduardo, DOUILLARD, Jean-Yves, HOCHSTER, Howard, MARTONI, Andrea, GROTHEY, Axel, HINKE, Axel, SCHMIEGEL, Wolff
Published in Journal of clinical oncology (20.12.2008)
Published in Journal of clinical oncology (20.12.2008)
Get full text
Journal Article
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8
Hecht, Markus, Gostian, Antoniu Oreste, Eckstein, Markus, Rutzner, Sandra, von der Grün, Jens, Illmer, Thomas, Hautmann, Matthias G, Klautke, Gunther, Laban, Simon, Brunner, Thomas, Hinke, Axel, Becker, Ina, Frey, Benjamin, Semrau, Sabine, Geppert, Carol I, Hartmann, Arndt, Balermpas, Panagiotis, Budach, Wilfried, Gaipl, Udo S, Iro, Heinrich, Fietkau, Rainer
Published in Journal for immunotherapy of cancer (01.10.2020)
Published in Journal for immunotherapy of cancer (01.10.2020)
Get full text
Journal Article
Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab - the randomized phase 2 FOCUS trial
Brandt, Anna, Schultheiss, Christoph, Klinghammer, Konrad, Schafhausen, Philippe, Busch, Chia-Jung, Blaurock, Markus, Hinke, Axel, Tometten, Mareike, Dietz, Andreas, Müller-Richter, Urs, Hahn, Dennis, Alt, Jürgen, Stein, Alexander, Binder, Mascha
Published in Frontiers in oncology (07.02.2024)
Published in Frontiers in oncology (07.02.2024)
Get full text
Journal Article
Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer
Tintelnot, Joseph, Ristow, Inka, Sauer, Markus, Simnica, Donjete, Schultheiß, Christoph, Scholz, Rebekka, Goekkurt, Eray, von Wenserski, Lisa, Willscher, Edith, Paschold, Lisa, Lorenzen, Sylvie, Riera-Knorrenschild, Jorge, Depenbusch, Reinhard, Ettrich, Thomas J, Dörfel, Steffen, Al-Batran, Salah-Eddin, Karthaus, Meinolf, Pelzer, Uwe, Hinke, Axel, Bauer, Marcus, Massa, Chiara, Seliger, Barbara, Wickenhauser, Claudia, Bokemeyer, Carsten, Hegewisch-Becker, Susanna, Binder, Mascha, Stein, Alexander
Published in Frontiers in oncology (20.12.2022)
Published in Frontiers in oncology (20.12.2022)
Get full text
Journal Article
Intensive Dose-Dense Compared With Conventionally Scheduled Preoperative Chemotherapy for High-Risk Primary Breast Cancer
UNTCH, Michael, MÖBUS, Volker, KAHLERT, Stephen, VON KOCH, Franz, PETRY, Karl Ulrich, WALLWIENER, Diethelm, KREIENBERG, Rolf, ALBERT, Ute-Susann, LÜCK, Hans-Joachim, HINKE, Axel, JÄNICKE, Fritz, KONECNY, Gottfried E, KUHN, Walther, MUCK, Bernd Rudolph, THOMSSEN, Christoph, BAUERFEIND, Ingo, HARBECK, Nadia, WERNER, Christoph, LEBEAU, Annette, SCHNEEWEISS, Andreas
Published in Journal of clinical oncology (20.06.2009)
Published in Journal of clinical oncology (20.06.2009)
Get full text
Journal Article
Phase I-II Trial of Cetuximab, Capecitabine, Oxaliplatin, and Radiotherapy as Preoperative Treatment in Rectal Cancer
Rödel, Claus, M.D, Arnold, Dirk, M.D, Hipp, Matthias, M.D, Liersch, Torsten, M.D, Dellas, Kathrin, M.D, Iesalnieks, Igors, M.D, Hermann, Robert Michael, M.D, Lordick, Florian, M.D, Hinke, Axel, M.D, Hohenberger, Werner, M.D, Sauer, Rolf, M.D
Published in International journal of radiation oncology, biology, physics (15.03.2008)
Published in International journal of radiation oncology, biology, physics (15.03.2008)
Get full text
Journal Article
Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer
Hecht, Markus, Eckstein, Markus, Rutzner, Sandra, von der Grün, Jens, Illmer, Thomas, Klautke, Gunther, Laban, Simon, Hautmann, Matthias G, Brunner, Thomas B, Tamaskovics, Bálint, Hinke, Axel, Zhou, Jian-Guo, Frey, Benjamin, Donaubauer, Anna-Jasmina, Becker, Ina, Semrau, Sabine, Hartmann, Arndt, Balermpas, Panagiotis, Budach, Wilfried, Gaipl, Udo S, Iro, Heinrich, Gostian, Antoniu-Oreste, Fietkau, Rainer
Published in Journal for immunotherapy of cancer (01.01.2022)
Published in Journal for immunotherapy of cancer (01.01.2022)
Get full text
Journal Article